Response to "Randomized controlled trial of remimazolam compared with placebo in Japanese patients undergoing upper gastrointestinal endoscopy: Phase III investigator-initiated clinical trial

被引：0
|
作者：
Ichijima, Ryoji [1 ]
Esaki, Mitsuru [2 ]
Ikehara, Hisatomo [1 ,3 ]
机构：
[1] Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan
[3] Kitasato Univ, Sch Med, Dept Gastroenterol, Internal Med, Sagamihara, Kanagawa, Japan
来源：
DIGESTIVE ENDOSCOPY | 2024年 / 36卷 / 11期
关键词：
D O I：
10.1111/den.14921
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1281 / 1281
页数：1
相关论文
共 50 条
  • [21] Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
    Goldsmith, Scott R.
    Covut, Fahrettin
    Fiala, Mark
    Xiang, Zhifu
    Iqbal, Zahid
    Moore, Nathan
    Bradtke, Elizabeth
    Christen, Brandon
    Rettig, Michael P.
    Christ, Stephanie
    Gehrs, Leah
    Street, Emily
    Wallace, Nicholas
    Ritchey, Julie
    Gao, Feng
    Pachter, Jonathan
    Parikh, Bijal
    Dubberke, Erik R.
    Dipersio, John F.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
  • [22] Treatment of arterial calcification in patients with chronic limb threatening ischemia with etidronate: protocol of an investigator-initiated multicenter, double blind, placebo-controlled, randomized clinical trial
    R. Hoogervorst
    H. van Overhagen
    P. A. de Jong
    W. Spiering
    G. J. de Borst
    H. T. C. Veger
    A. T. A. Mairuhu
    W. P. T. M. Mali
    CVIR Endovascular, 5
  • [23] Treatment of arterial calcification in patients with chronic limb threatening ischemia with etidronate: protocol of an investigator-initiated multicenter, double blind, placebo-controlled, randomized clinical trial
    Hoogervorst, R.
    van Overhagen, H.
    de Jong, P. A.
    Spiering, W.
    de Borst, G. J.
    Veger, H. T. C.
    Mairuhu, A. T. A.
    Mali, W. P. T. M.
    CVIR ENDOVASCULAR, 2022, 5 (01)
  • [24] Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial
    Huichen Zhu
    Zhongxue Su
    Xiaorong Huai
    Caiyang Chen
    Xiao Zhang
    Jie Zhou
    Diansan Su
    Trials, 23
  • [25] Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial
    Jing Wang
    Xinyan Wang
    Haiyang Liu
    Ruquan Han
    BMC Anesthesiology, 23
  • [26] Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial
    Zhu, Huichen
    Su, Zhongxue
    Huai, Xiaorong
    Chen, Caiyang
    Zhang, Xiao
    Zhou, Jie
    Su, Diansan
    TRIALS, 2022, 23 (01)
  • [27] Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial
    Wang, Jing
    Wang, Xinyan
    Liu, Haiyang
    Han, Ruquan
    BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [28] The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial
    Chen, Shaohui
    Wang, Jin
    Xu, Xiaohan
    Huang, Yuguang
    Xue, Shanfu
    Wu, Anshi
    Jin, Xiaoju
    Wang, Qiang
    Lyu, Jianrui
    Wang, Sheng
    Li, Yujuan
    Yu, Yonghao
    Ai, Dengbin
    Luo, Ailin
    Min, Su
    Li, Lin
    Zou, Xiaohua
    Liu, Jin
    Lv, Peilin
    Chai, Xiaoqin
    Sun, Xude
    Zhao, Zhibin
    Zhang, Jiaqiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (08): : 4594 - 4603
  • [29] Effect of virtual endoscopy simulator training on performance of upper gastrointestinal endoscopy in patients: a randomized controlled trial
    Ferlitsch, A.
    Schoefl, R.
    Puespoek, A.
    Miehsler, W.
    Schoeniger-Hekele, M.
    Hofer, H.
    Gangl, A.
    Homoncik, M.
    ENDOSCOPY, 2010, 42 (12) : 1049 - 1056
  • [30] Topical simvastatin for porokeratosis ptychotropica: A randomized, single-blind, split-body, placebo-controlled investigator-initiated trial
    Chen, Z.
    Liu, Y.
    Yu, H.
    Chen, H.
    Yang, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S106 - S106
12345